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Abstract      
Typhoid and paratyphoid (enteric) fever are responsible for morbidity and mortality 
worldwide. Bangladesh is an endemic zone of enteric fever where sanitation and hygienic 
conditions are poor. Rapid, accurate diagnosis of enteric fever and early treatment of the 
patients with appropriate antimicrobials are essential for recovery and for prevention of 
complications and death. Bone marrow culture is the gold standard for diagnosis of 
enteric fever but it is an invasive procedure and blood culture method and widal test have 
low sensitivity and specificity respectively. Thus development of an early and reliable 
diagnostic method is necessary. Previous studies reported that a novel diagnostic method, 
TPTest is very useful for diagnosis of typhoid and paratyphoid fever and it gives a 
preliminary result within 24 hours and a confirmatory result after 48 hours. The 
sensitivity and specificity of the TPTest are 100% and 78-97% respectively. The TPTest 
detects Salmonella enterica serotype Typhi specific antibodies in peripheral blood 
antibodies (PBA) specimen by ELISA. The PBA specimen is prepared by isolating the 
lymphocytes form whole blood using ficoll density gradient centrifugation method and 
culturing the cells at 37oC with 5% CO2 supplementation. For implication of the TPTest 
in laboratories with less facilities and expertise immunodot blot assay was used to detect 
the response in PBA specimen. The specimen was prepared by isolating the blood cells 
using RBC lysis and culturing the cells at 37oC with no 5% CO2 supply. In this study, 
optimization of the simplified methods of the TPTest was done at different stages and the 
results were evaluated with the results of blood culture and with the standard TPTest 
method. The findings of this study suggest that the optimized immunodot blot assay and 
the simplified cell separation methods will be helpful for diagnosis of typhoid and 
paratyphoid fever.       
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Introduction 
1.1 Background 
Enteric (typhoid and paratyphoid) fever is a serious and sometimes life-threatening 
infection. Enteric fever is referred to as typhoid fever when it is caused by Salmonella 
enterica serovar Typhi (S.Typhi) and paratyphoid fever when it is caused by Salmonella 
enterica serovar Paratyphi (S. Paratyphi) A, B and C [1]. Enteric fever is common in 
resource-limited regions in the world with lack of proper sanitation and poor hygiene [2]. 
 
1.2 Epidemiology of enteric fever  
 
1.2.1Global epidemiology 
Typhoid fever is a major cause of morbidity [3]. It is estimated global incidence of 21.6 
million cases and 216,510 deaths worldwide in 2000 [4] [5]. Particularly typhoid fever 
burden assumed to be underestimated in urban areas. It has been controlled by good 
sanitation and chlorination of drinking water in the developed countries. But poor 
sanitation, poverty and contaminated water cause 5% or more deaths due to typhoid fever 
in the developing countries [3]. Each year Salmonella enterica serotype Paratyphi A 
infections also causes an additional 5 million cases of enteric fever [6]. 
High incidence of enteric fever (>100/100,000 cases/year) is observed in south-central 
Asia and south-east Asia whereas regions of medium incidence (10-100/100,000 
cases/year) include the rest of Asia, Africa, Latin America, and Caribbean and the 
Oceania, except for Australia and New Zealand. Europe, North America and the rest of 
the developed world have low incidence of enteric fever (<10/100,000 cases/year) [7] [8]. 
Salmonella enterica serovar Paratyphi A (S.Paratyphi A) is assumed to cause less severe 
enteric fever than Salmonella enterica serovar Typhi (S.Typhi) [9]. S. Paratyphi A is 
liable for approximately 5 million illnesses in the 2000 [1]. 
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Figure 1: Global incidence of enteric fever [10] 
 
Peak incidence of typhoid fever is reported to occur in children 1–15 years of age. 
Children less than 5 years of age have the highest infection rates. Paratyphoid fever has a 
similar clinical feature of typhoid fever [5]. 
 
Figure 2: Distribution of enteric fever by age [5] [11] 
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1.2.2. Epidemiology of enteric fever in Bangladesh 
In Bangladesh the incidence of typhoid fever is high in the urban population. The greatest 
incidence of infection is in children less than 5 years of age [12] [13] [14].53% of typhoid 
fever cases in the community are seen in this group. 85% of cases occurring among 
children aged 1-4 years of age. The overall incidence of typhoid fever is 3.9/1,000 
persons per year, but in young children it is 18.7/1,000 persons per year. Typhoid fever 
among pre-school children varied by age, with 4% in the first year of life and 85% 
occurring in those 2 to 4 years of age [15] [13]. Additionally, young children appear to be 
clinically more ill symptoms compare to older persons. Typhoid vaccines so far 
developed are not effective in children. So vaccine development against typhoid fever is 
needed for children aged less than 2 years to protect them from the infection [16] [17] 
[18]. The incidence of paratyphoid fever was 0.4/1000 person per year without variation 
by age group [12]. 
 
 
Figure 3: Age distribution of typhoid cases for patients <5 years of age, Kamalapur 2001 
[14]. 
 
 
19 
 
1.3 Classification, structure, antigenic type of Salmonella Typhi 
1.3.1 Classification 
All of the Salmonella serovar belong to two species: Salmonella bongori containing eight 
serovar and Salmonella enterica containing the remaining 2300 serovar divided among 
six subspecies [19]. 
 Salmonella enterica subspecies enterica 
 Salmonella enterica subspecies salamae 
 Salmonella enterica subspecies arizonae 
 Salmonella enterica subspecies diarizonae 
 Salmonella enterica subspecies houtenae 
 Salmonella enterica subspecies indica 
 
 
Figure 4: Phylogenetic Tree of the evolution of Salmonella species within closely related 
families [19]. 
 
Salmonella 
bongori 
Salmonella 
enterica 
20 
 
Among them Salmonella enterica serovar Typhi and Salmonella enterica serovar 
Paratyphi are the causative agents for enteric fevers: typhoid and paratyphoid 
respectively. 
1.3.2 Structure 
Salmonella Typhi is a gram-negative, flagellate, encapsulated, nonsporulating, facultative 
anaerobic bacteria in the family of Enterobacteriaceae. The organism is rod shaped 
(bacilli), 2-3 m long and 0.4-0.6 m in diameter. The inner and outer membranes of 
salmonella are separated by the murein cell wall layer and flagella are attached at basal 
bodies. Fimbriae are thinner and shorter than flagella and are displayed more densely 
around the cell [20] [21]. 
 
 
Figure 5: Physical structure Salmonella enterica serovar Typhi and Paratyphi [20] 
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Figure 6: Physical structure Salmonella enterica serovar Typhi and Paratyphi [20] 
 
1.3.3 Genome structure of Salmonella Typhi 
The full genome of Salmonella enterica serovar Typhimurium strain LT2 is 4.8-Mb. The 
plasmids are 218 kb and 106 kb. These plasmids have different drug resistant bands [22]. 
 
Figure 7: Salmonella enterica serovar Typhimurium LT2 genome. (a)The black inner 
circle is G+C content and the purple or yellow innermost circle is GC bias [22] 
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1.3.4 Antigenic types of Salmonella Typhi 
Salmonella has three kinds of major antigens with identifying applications:  
 
1.3.4.1 O antigens or somatic antigens 
 
Somatic or cell wall antigens also known as O antigens. These antigens are bacterial 
endotoxin which causes fever. Somatic antigens are heat stable and alcohol resistant. It 
has a significant effect on the interaction between a bacterial pathogen and the host 
organism. Antibodies directed against O antigen are vital to the immune response to 
infection [23] [21]. 
 
1.3.4.2 H (flagellar) antigens 
The H antigens are present in flagella and composed of protein subunits called flagellin. 
Flagellar antigens are heat-labile proteins and also alcohol labile. This antigen does not 
have any significant effect on the virulence of S. Typhi. Mixing Salmonella cells with 
flagella-specific antisera gives a characteristic pattern of agglutination. They are well 
preserved in 0.2 % formaldehyde.  Flagella of S. Typhi induce different pro-inflammatory 
cytokines [24, 25] [26] [27]. 
 
1.3.4.3 Vi – antigen 
The surface Vi (for virulance) antigen, a polysaccharide on the exterior of the cell wall. 
This Vi polysaccharide antigen prevents O antibodies from binding to the O antigen. 
Surface antigens in Salmonella may mask O antigens. The bacteria will not be 
agglutinated with O antisera [28] [29] [30] [31]. 
 
The cell envelope of Salmonellae contains a complex lipopolysaccharide (LPS) structure. 
The lipopolysaccharide moiety may function as an endotoxin. These may be important in 
determining virulence of the organisms. This macromolecular endotoxin complex 
consists of three components: 
  An outer O-polysaccharide coat
 A middle portion (polysaccharide core)
 An inner lipid A coat
 
Figure 8: Antigenic structure of 
 
1.3 Molecular and biologic features of 
 
A comparison of S. Typhi 
related and that they emerged from a single point of origin approximately 30,000 to 
50,000 years ago. Different str
of plasmids which usually carry virulence or antibiotic resistance genes 
 
 
 
 
 
 
Figure 9: Molecular and Biologic Features of 
 
 
 
 
S. Typhi and S. Paratyphi [31]
Salmonella Typhi  
isolates from around the world indicates that they are highly 
ains may also harbor extrachromosomal DNA in the form 
[32]
Salmonella Typhi
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1.5 Type three secretion systems (TTSS) of bacteria to translocate virulence factors 
to the host during infections 
After a foreign genome is integrated into the bacterial chromosome the genes for 
virulence factors cluster in Pathogenicity islands (PI). Non-pathogenic related species of 
Salmonella do not have PIs. PIs gene expression is generally limited to specific host 
compartments [34]. 
 
 
Figure 10: Type Three Secretion Systems (TTSS) of Bacteria to Translocate Virulence 
Factors to the Host During Infections [35] 
 
1.6 Pathogenesis of enteric fever 
The approximate number of bacteria that must be ingested to cause symptomatic disease 
in healthy adults is 106- 108 Salmonella organism. Most organisms are rapidly killed at 
gastric pH ≤2. The gastric acidity inhibits multiplication of the Salmonellae. 
Achlorhydria, buffering medications, rapid gastric emptying after gastrectomy or 
gastroenterostomy and a large inoculum enable viable organisms to reach the small 
intestine. Neonates and young infants have hypochlorhydria and rapid gastric emptying, 
which contribute to their increased vulnerability to symptomatic Salmonellosis. In infants 
 who typically take fluids, the inoculum size that can produce disease is also 
comparatively smaller because of faster transit through the stomach 
Figure 11: 
 
1.7 Transmission and risk factors of enteric fever
Risk factors for enteric fever have been identified in several epidemiologic studies, for 
example- waterborne [37]
host and reservoirs for S.
1.5. Stomach acidity is decreased by antacids, histamine
blockers), proton pump inhibitors, gastrectomy and achlorhydria wh
infection [41]. The significant association has been found betwee
anti-Helicobacter pylori 
varies between 103 to 106 
Bangladesh has been found that raw papaya is big threat for this disease. The pH of 
papaya is neutral. It can support the growth of various microorganisms. An 
environmental and behavioral risk factors that are independently associated with enteric 
[36].
Pathogenesis of Typhoid Fever [36] 
 
 
 [38]or food borne transmission [39]. Humans are the natural 
Typhi [40]. S.Typhi is able to survive a stomach pH as low as 
-2 receptor antagonists (H2 
ich facilitate 
n the presence of serum 
IgG antibodies and typhoid fever [42]. The infectious dose 
organisms which given orally. The present study from slums in 
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S. Typhi 
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fever. Eating food from street vendors, living in the same household with someone who 
has new case of enteric fever, washing the hands inadequately, sharing food from the 
same plate, drinking unpurified water and living in a household that does not have a toilet 
are the risk factors of enteric fever [7]. Some hospitals that are situated as the middle 
class in South Asia seeing a large number of typhoid fever cases among relatively well-
off university students who lives in group house-hold with poor hygiene [43]. 
 
1.8 Clinical manifestations of enteric fever 
 
The clinical manifestation of enteric fever may vary widely. It largely depends on the 
patient population, for example-adults versus infants studied. Enteric fever is a disease of 
children and young adults. Most patients who present to hospital with enteric fever are in 
the age class of 5 to 25 years. Many cases of typhoid particular in children less than five 
years of age [13]. Many patients with enteric fever do not receive appropriate medical 
treatment in most of the developing countries [44]. The temperature increase daily (up to 
40 to 410C) combined with headache, malaise and chills [45]. The hallmark of typhoid 
fever is prolonged fever. The fever may persist up to 4 to 8 weeks in untreated case [46]. 
The illness may be mild and brief. In rare cases an acute severe infection progresses into 
multiple organ failure, disseminated intravascular coagulation and central nervous system 
involvement and may results in early death [47]. 
 
1.9 Typhoid carrier state 
 
Human are the sole reservoir for Salmonella Typhi infection. There are two types of 
infection- 
 Asymptomatic 
 Symptomatic 
The percentage of people who infected with S.Typhi is 1 to 5%. They become 
asymptomatic chronic carrier and continue to excrete bacteria through their feces or 
urine. The frequency of chronic carriage is higher among women. These women have 
billiary tract infection, for example-gallstone. The tendency to become a chronic carrier 
 may increase by improper treatment of antibiot
handle food without proper hygiene can transmit infection. The classical story of 
‘Typhoid Mary’ spreading typhoid infection is well known. She was responsible for an 
outbreak of typhoid fever in New York in 1906. H
known as Typhoid Mary 
 
 
1.10 Persistent Salmonella
 
Bacteria enter the Peyer's patches of the intestinal tract mucosal surface by invading M 
cells specialized epithelial cells that take up and transcytose luminal antigens for uptake 
by phagocytic immune cells. This is followed by inflammation and phagocytes of 
bacteria by neutrophils and macrophages and recruitment of T and B cells .In systemic
salmonellosis, such as typhoid fever, 
as dendritic cells and/or macrophages that 
and blood stream to the mesenteric lymph nodes (MLNs) and to deeper tissues.
leads to transport to the spleen, bone marrow, liver and gall bladder. Bacteria can persist 
in the MLNs, bone marrow and gall bladder for life and periodic reseeding of the 
mucosal surface via the bile ducts and/or the MLNs of the small intestin
shedding can take place from the mucosal surface. Interferon
secreted by T cells has a role in maintaining persistence by controlling intracellular 
replication. Interleukin-12 (IL
Salmonella proinflammatory cytokine tumour
to the control of persistent 
 
 
 
ic and antibiotic resistance. People who 
er name was Mary Million but better 
[48]. 
 infection 
S. Typhi may target specific types of host cells, such 
favor dissemination through the lymphatics 
-  (IFN-
-12) which can increase IFN-  production a
-necrosis factor-  (TNF-
Salmonella [49]. 
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 This then 
e occur and 
) which can be 
nd the 
) also contribute 
 Figure 12: Schematic Representation of Persistent Infection with 
 
1.11 Host defense system
 
1.11.1 Mucosal immune response to 
The gut microflora is able to passively restrict 
depleted environment, by releasing by products of their metabolic activities such as 
propionate or butyrate. It can be harmful to 
The epithelial cell layers also help to maintain by secreting mucus (goblet cells) or 
antimicrobial peptides (peneth cells). Underlying this epithelial cell layer is the lamina 
propria. It contains a highly organized lymphoid tissue commonly refe
Associated Lymphoid Tissue (GALT). The GALT is composed of T cells and B cells, 
dendritic cells, macrophage and neutrophils. These cells coordinate inflammatory 
response to bacteria and antigens that break the gastrointestinal barrier. Accum
lymphoid follicles which called Peyer’s patches, are surrounded by a particular 
epithelium. The follicle associated epithelium forms the interface between the GALT and 
Salmonella enterica
serovar Typhi in Humans [49] 
 
Salmonella  
Salmonella growth by creating a nutrient 
Salmonella, or by production of bact
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the luminal microenvironment. It has an important role in the immune surveillance of the 
intestinal lumen [50] [51]. 
 
 
 
Figure 13: Schematic representation showing the different routes Salmonella can take in 
order to invade the intestinal mucosa [50] 
 
1.11.2 Cell mediated immune response to Salmonella 
The cell-mediated immunity plays a vital role in controlling Salmonella infection [52] 
[53]. Salmonella infection induces the generation of specific CD41 and CD81 T cells. 
CD41 and CD81 T cells populations are important for protection during primary and 
secondary responses, although the mechanisms underlying T cell-mediated protection are 
not yet completely understood [54] [55] .During the initial period there was increased 
production of interleukin (IL)-2 and interferon (IFN)- γ producing cells in the spleen and 
Peyer’s patches, indicating a Th1 type response, whereas in the later period of the study, 
increased production of IL-4 producing cells suggested a Th2 type response [56] [54] 
[57] [58]. 
 
 1.11.3 Circulating antibody response to 
Antibodies, also called Immunoglobulins or Ig’s constitute the 
the blood proteins. They are soluble proteins secreted by the plasma offspring of primed 
B cells and react specifically
Antibodies inactivate antigens by (a) complement fixa
surface and cause holes to form, i.e., cell lysis), (b) neutralization (c) agglutination 
(clumping), and (d) precipitation. IgG is the predominant antibody in the secondary 
response and constitutes an important defense agai
antibody that can cross the placental barrier to the fetus. It is responsible for the 3 to 6 
month immune protection of newborns that is conferred by the mother. IgA is the main Ig 
in secretions such as colostrums, 
secretions. It prevents attachment of microbes to the mucous membranes. 
Ig produced early in the primary response. It has the highest avidity and is most efficient 
in agglutination, complement fixation and other antibody reactions. IgE mediates 
anaphylaxis and defends host against certain parasites 
 
 
 
 
 
 
 
 
 
 
Figure 14: 
Salmonella 
gamma globulin
 to the antigen that stimulated their production 
tion (proteins attach to antigen 
nst bacteria and viruses. It is the only 
saliva, tears, and respiratory, intestinal and genital 
[59]. 
B-Cell Proliferation and differentiation [60] [61]
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[58]. 
IgM is the main 
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1.12 Clinical features of enteric fever 
The clinical feature of typhoid fever is highly fluctuating, ranging from fever and to a 
severe systemic illness. It is associated complications involving many systems. The fever 
might rise gradually in a sidewise manner. With 5 to 7 days of daily increments in most 
temperature to 0.5 to 10C. This temperature becomes constant and high grade 39.5 to 
410C by the second week of illness. So this high fever can continue up to 4 weeks, if left 
untreated then followed by return to normal temperature. Present study advises the 
pattern of morbidity and mortality associated with typhoid fever is reliant on age and 
gender [62] [63] [64]. Some people with typhoid fever develop a rash called “rose spots”, 
which are small red spots with the abdomen and chest. Other symptoms that occur 
include [65] [66] - 
 Abdominal tenderness 
 Agitation 
 Bloody stools 
 Chills 
 Confusion  
 Difficulty paying attention (attention deficit) 
 Delirium  
 Fluctuating mood 
 Hallucinations 
 Nosebleeds 
 Severe fatigue 
 Slow, sluggish, lethargic feelings 
 Weakness 
1.13 Complications of enteric fever 
 One of the most lethal complications of typhoid fever is ileal perforations. When 
treatment is interrupt, ileal perforation is occurred [67] [68] [67]. 
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 Salmonella enteric serovar Typhi splenic abscesses are traditionally considered to 
be a rare complication of typhoid fever but sometimes it is observed in case of 
untreated patients [69] [70] [71] .  
 Hepatic dysfunction is clinical complications during pregnancy [72] . 
 Gall bladder perforation is rare complications of typhoid fever [73] [74]. 
 Acute disseminated encephalomyelitis in typhoid fever [75] [75]. 
 Patients suffering from Small bowel perforation in secondary infection [76]. 
1.14 Treatment of enteric fever 
The emergence of antibiotic resistant strains of Salmonella Typhi is major problem of 
treatment of typhoid fever in recent years [77]. Some variants of Salmonella Typhi have 
developed multidrug-resistance as an integral part of the genetic material of the organism. 
Drug-resistant Salmonella Typhi emerges in response to antibiotic usage, if the dose is 
not properly determined and time course is not followed. Selective pressure from the use 
of antibiotic is a major driving force behind the emergence of resistance, but other factors 
also need to be taken into consideration.  
The available antibiotics against S.Typhi are Ampicillin, Chloramphenicol, 
Trimethoprim-sulfamethoxazole, Ceftriaxone, Ciprofloxacin, Nalidixic acid, Cefixime 
and Gentamicin [78]. All of antibiotics resistance S. Typhi is emerged except Ceftriaxone 
and Cefixime [79]. In some place it is reported that Cefixime and Ceftriaxone resistance 
S. Typhi are evolved. Recently Azithromycin is most commonly used in Bangladesh for 
treatment of typhoid fever. It is very effective in treatment of multidrug-resistant typhoid 
fever. In case of Ciprofloxacin sensitive but Nalidixic acid resistance, Ciprofloxacin is 
not effective to kill pathogens. Though Fluoroquinolones were thought to be the most 
effective treatment option for the multiple-drug resistance typhoid fever, emergence of 
Fluoroquinolones resistant strains has aggravated the problem [95, 96]. In Bangladesh the 
prevalence of Fluoroquinolones especially ciprofloxacin resistant S. Typhi is more 
pronounced [80] [81, 82] [83]. 
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1.15 Prevention of enteric fever 
Safe water: Enteric fever is a waterborne disease and the main preventive measure is to 
ensure access to safe water. The water needs to be of good quality and must be sufficient 
to supply all the community with enough drinking water as well as for all other domestic 
purposes such as cooking and washing [84] 
Food safety: Contaminated food is another important vehicle for typhoid fever 
transmission. Appropriate food handling and processing is paramount and the following 
basic hygiene measures must be implemented or reinforced during epidemics: 
Sanitation: Proper sanitation contributes to reducing the risk of transmission of 
pathogens including Salmonella Typhi [84]. 
Health education: Health education is paramount to raise public awareness that can be 
an effective measure for reducing risk of transmission of S. Typhi [84]. 
 
1.16 Vaccination 
1.16.1 Ty21a live oral vaccine 
This is an oral vaccine containing live attenuated Salmonella Typhi Ty21a strains in enteric 
coated capsules. It consists of one enteric-coated capsule that is taken every two days, a 
total of 3 doses. The capsule must be refrigerated but not frozen to achieve maximum 
efficacy. Each capsule is taken with one glass of water. The vaccination is completed in a 
week and the booster dose should be given every 5 years. The vaccine recipient should not 
be younger than 6 years.  The vaccine elicits both serum and intestinal antibodies and cell 
mediated immunity though, the detailed mechanism of vaccine induced immune response 
is unknown [85]. 
1.16.2 Vi capsular polysaccharide vaccine 
This vaccine is composed of purified Vi ("virulence") capsular polysaccharide antigen of 
Salmonella Typhi isolated from blood cultures.  This capsular polysaccharide of S. Typhi 
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is conjugated to nontoxic recombinant Pseudomonas aeruginosa exotoxin A and 
enhances immunity. It is given by the parenteral route and only one is needed. This 
vaccine must be kept at 4C temperatures. Children below two years of age are not given 
this vaccine. Since it is not effective or immunogenic in them a booster dose is given 
every 2 years to maintain protection if the exposure of Salmonella is expected. It is T-cell 
independent and, thus, cannot stimulate protective T helper cells or is used in young 
children [86] [17]. 
1.17 Diagnosis of enteric fever 
 
The diagnosis of typhoid fever depends on the isolation of S.Typhi from blood, bone 
marrow and specific lesion. The existence of clinical symptoms characteristic of typhoid 
fever or the detection of a specific antibody response is symbolic of typhoid fever but not 
reliable. Blood culture is the mainstay of the diagnosis of this disease [84]. 
 
1.17.1 Culture methods 
 
The diagnosis of enteric fever is ultimately based on isolation and identification of the 
bacterium in cultures.  Salmonella Typhi are usually isolated from cultures of blood or 
bone marrow only during the first 2 weeks of illness [87].The various culture methods 
available are- 
 Blood culture 
 Stool culture 
 Urine culture 
 Bone marrow culture 
 Bile culture 
Blood culture: 
This is the method of choice and has the great advantage over culture from the urine or 
bile showing not only that the patient is infected with the bacillus but that the infection is 
active and is almost certainly responsible for the disease from which he or she is 
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suffering [87]. Microbiologic culturing of blood is approximately 30 to 50% sensitive 
even under the best conditions; there may be failure to isolate the organism [6].Blood 
culture cannot isolate pathogen in case empirical (without knowing causative microbes) 
treatment of antibiotics [88]. 
Stool culture: 
Stool culture is another way of identifying the Salmonella Typhi organism from infected 
person. Stool specimens should be examined and cultured as soon as possible after 
collection. As the stool specimen cools, the drop in pH soon becomes sufficient to inhibit 
the growth of Salmonella species. A small amount of faecal specimen can be added to 
selenite broth for enrichment [87]. 
Urine culture: 
Except for urethral mucosa, which supports the growth of a microflora, the normal 
urinary tract is usually devoid of bacteria. Proper collection of sample is very important 
for optimum recovery of pathogens [87]. 
Bone marrow culture: 
 
Bone marrow culture is more sensitive than blood culture. It is more invasive procedure. 
It is possible to isolate the offending organisms from the bone marrow [89] . 
Bile culture: 
Bile is a good culture medium for Salmonellae. They can be successfully recovered from 
culture of bile, especially from chronic carriers. Several milliliters of bile are collected in 
a sterile container. The sample is plated on blood agar and MacConkey agar plate and 
incubated at 37° C for 24 to 48 hour or until growth is obtained. It is an invasive 
technique [87]. 
 
 
36 
 
1.17.2 Widal test 
Widal test is used for enteric fever diagnosis due to the complexity of performing blood 
culture [106]. Widal is an immunoagglutination method which detects anti-O and anti-H 
antibody response in blood of enteric fever patient. Widal is rapid diagnostic method and 
easy to perform. But false-positive results are common because of antigenic cross sharing 
with other Salmonella serotypes, other Enterobacteriaceae, and with previous history of 
diseases such as malaria, dengue, and typhoid [90] [91] [41]. The Widal test also has low 
sensitivity, specificity and practically not being used by clinicians in this setting [41]. 
 
1.17.3 Enzyme-Linked Immune Sorbent Assay (ELISA) 
ELISAs can be performed with a number of modifications to the basic procedure. The 
key step, immobilization of the antigen of interest can be accomplished by direct 
adsorption to the assay plate or indirectly via a capture antibody that has been attached to 
the plate. Antigens from the sample are attached to a surface. A further specific antibody 
is applied over the surface. So it can bind to the antigen. This antibody is linked to an 
enzyme. In the final step a substance containing the enzyme substrate is added. The 
subsequent reaction can produce a detectable signal, most commonly a color change in 
the substrate [92] 
 
 
Figure 15: Assay of Antibody by ELISA[92] 
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1.17.4 Diagnosis of enteric fever using TPTest (Typhoid and Paratyphoid Test) and 
simplified methods of TPTest 
The TPTest is an immunodiagnostic method that detects IgA antibody response in 
lymphocyte culture secretion by ELISA and used for diagnosis of enteric fever. This 
method gives a presumptive result within 24 hours and a confirmatory result after 48 
hours and 64% positive result become positive within 24 hours. The sensitivity and 
specificity of the TPTest are 100% and 78-97% respectively [6, 93, 94]. 
In a earlier study, simplification of the TPTest was done at different stages of the method 
for implication of the TPTest at laboratories with less facilities and equipments [6]. Cell 
separation method was simplified by RBC lysis and buffy coat methods. Incubation of 
the isolated cells was done at 37oC with 5% CO2 and without 5% CO2 supplementation 
and the antibody responses in culture supernatants were compared. Immunodot blot assay 
has been evaluated for identification of antibodies in lymphocyte culture supernatant and 
compared with the results of the standard TPTest. It has been found that immunodot blot 
assays could not detect positive samples of the TPTest having a value of ≤16 EU (cut-off 
of the TPTest: equal or less to 10 EU).  
 
Figure 16: Immunodot blot assay for detecting antibody [6] 
 
38 
 
1.18 Hypothesis 
Enteric fever can be diagnosed by measuring antibodies in lymphocyte secretion by the 
TPTest and its simplification is possible for use at the laboratories with less facilities and 
equipments.  
 
1.19 Overall objective of the study  
Previous study demonstrated that the TPTest specimens with values ≥16 ELISA unit can 
be detected by the immunodot blot assay. The aim of this study was to optimize the 
immunodot blot assay for diagnosis of the patients with positive TPTest result. 
 
1.20 Specific objectives 
a) To isolate and identify the organism using blood culture method from the patients 
with enteric fever. 
b) To find out the antibiotic susceptibility pattern of the isolated strain. 
c) To optimize the immunodot blot assay and to evaluate the assay with TPTest 
using ELISA. 
d) To compare the performance of simple cell separation methods, such as RBC 
lysis with the density gradient centrifugation method of the standard TPTest.  
e) To compare the effect of cell culture in an incubator without 5% CO2 
supplementation with the existing cell culture incubation requiring 5% CO2 
supply. 
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Chapter 2 
Materials and Methods 
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Materials and Methods 
2.1 Place of the study 
This study was carried out in the Enteric Vaccine, Centre for Vaccine Science (CVS), 
International Centre for Diarrhoeal Disease and Research, Bangladesh (icddr,b).  All the 
patients were enrolled from icddr,b hospital, Mirpur and Kamalapur. 
2.2 Ethical issue 
The study was approved by the Research Review Committee (RRC) and the Ethical 
Review Committee (ERC) of icddr,b. Before enrollment in the study, written consent was 
taken from the patients and/or legal guardian of the patients in case of children. The risks 
and benefits had been explained in the consent form. 
2.3 Study participants 
Written informed consent for the study was obtained from 107 patients admitted to 
Mirpur, Kamalapur and icddr,b hospital with enteric fever and Positive for Salmonella 
Typhi infection. Blood samples were obtained during infection on Day 0, Day 7 and Day 
21.  
2.4 Inclusion criteria 
 High Fever : ≥39.20C 
 Duration of Fever: 3 to 7 days 
 
2.5 Period of the study 
The study was carried out from August 2013 to May 2014. 
 
 
 2.6 Blood sample collection 
 
 
Figure
 
 
 
 
 
 
 
 
Enrollment of Patients (n=107)
Day 0 (Blood Sample Collection)
If blood culture or TPTest Positive                                             
Day 7(Blood Sample Collection)
Day 21 (Blood Sample Collection)
  
 
 17: Blood Sample Collection Schedule 
Clinical Evaluation
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2.7 Flow chart of the study design 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Flow Chart of the study design 
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2.7.1 Blood culture 
3 ml of blood was added to enrichment broth incase of children (1-4 years) other wise 5 
ml blood was collected from 5-46 year old patients. Most cultures are monitored for five 
to seven days. BacT/ALERT 3D was used to incubate Bacteria at 370C.  The 
BacT/ALERT 3D instrument is a state-of-the-art, automated microbial detection system. 
The BacT/ALERT system offers advantages in every dimension of microbial detection 
testing. BacT/ALERT 3D is used for monitoring the presence or absence of 
microorganisms in broth. Any growth in enrichment broth is subsequently sub-cultured 
onto agar plates to isolate the pathogenic organism. Then S. Typhi can be confirmed by 
anti-sera test and biochemical tests. 
 
2.7.1.1 Anti-Sera test 
Salmonella tests are performed for determination of serological differentiation of 
Salmonella species. Anti-sera are used in qualitative slide agglutination test. Using these 
antisera Salmonella isolates in different types which are classified as S.Typhi and 
S.Paratyphi A and S.Paratyphi B. 
First marked the slide into three division using glass marker. Then added 10 µl O 
Polyvalent antiserum into one division. After that a loop of 3 single bacterial colony 
using inoculating tips. Mixed the reagents by tilting the glass slide back and forth for 1 
minute and the agglutination pattern were observed. Agglutination was grossly observed 
with light through the slide. Only strong agglutination was observed within 1 minute 
should be regarded as Salmonella species. 
Then added 10 µl Vi polysaccharide antigen into another division. After that a loop of 3 
single bacterial colony using inoculating tips. Mixed the reagents by tilting the glass slide 
back and forth for 1 minute and the agglutination pattern were observed. Agglutination 
was grossly observed with light through the slide. Only strong agglutination was 
observed within 1 minute should be regarded as Salmonella Typhi. 
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Then added 10 µl S-Poly A antigen into another division. After that a loop of 3 single 
bacterial colonies using inoculating tips. Mixed the reagents by tilting the glass slide back 
and forth for 1 minute and the agglutination pattern were observed. Agglutination was 
grossly observed with light through the slide. Only strong agglutination was observed 
wihin 1 minute should be regarded as Salmonella Paratyphi A. 
Then added 10 µl S-Poly B antigen into another division. After that a loop of 3 single 
bacterial colony using inoculating tips. Mixed the reagents by tilting the glass slide back 
and forth for 1 minute and the agglutination pattern were observed. Agglutination was 
grossly observed with light through the slide. Only strong agglutination was observed 
within 1 minute should be regarded as Salmonella Paratyphi B. 
Then added 10 µl of PBS into another division. After that a loop of bacterial colony using 
inoculating tips. Mixed the reagents by tilting the glass slide back and forth for 1 minute 
and the agglutination pattern were observed. Agglutination was grossly observed with 
light through the slide. No agglutination was found. So this method was correct for 
Salmonella Typhi and Salmonella Paratyphi. 
 
2.7.1.2 Biochemical test 
Biochemical tests is confirmed whether the colonies resembling Salmonella on XLD and 
BGA. These tests are described except that the Urease test is performed with urea broth 
instead of urea agar.  
 
  
Klinger’s Iron Agar (KIA):
This is a complex medium 
amount of glucose, a pH indicator (yellow in acid and red in base). It also contains iron 
which is precipitated as a black sulfide if H
determining four biochem
A. Lactose (+) or (
fermentation of carbohydrates present in high concentration (in this case lactose) 
yield more acidic products than can be oxidized to neutrality
organisms yields a yellow slant and lactose (
B. Glucose (+) or (-): In the largely anaerobic butt of the tube, even fermentation of 
the trace concentrations of glucose yields enough acid to change the pH. Thu
glucose (+) organisms also a yellow butt. Fermentation of lactose in the butt will 
obviously also change the pH. This does not confuse the interpretation since all 
 
Figure 19: Biochemical Test Tube 
 
that contains a large amount of lactose and a very small 
2S is produced. These ingredients allow 
ical properties of unknown organism. 
-): At the surface of the slant (aerobic conditions), only 
. Thus lactose (+) 
-) organisms yield a red slant.
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lactose positive organisms are also glucose-positive. If a black color from iron 
sulfide obscure the butt can presume it is yellow. 
C. H2S (+) or (-): if an organism forms H2S, the lower portion of the tube will turn 
black, due to formation of iron sulfide. 
D. Gas formation (+) or (-): If an organism’s forms gas from glucose or lactose the 
agar in the butt will show bubbles or cracks. 
 
Motility Urea Indole Medium: This medium is a multi-purpose medium for 
differentiation of Enterobacteriaceae that combines three individual tests into a single 
medium. Indole is tested by layering a small amount of Indole reagent onto the surface of 
the medium and allowed a few minutes to react. A positive result is indicated by the 
formation of a red line at the interface of the reagent and the medium. 
Appearance: Liquid 
Color: Golden 
pH: 6.8 ±0.2 
Recommend Incubation: Aerobically at 37±C for 18-24 hours 
Shelf Life: 182 Days. 
Citrate Agar: Citrate agar slants contain sodium citrate (only carbon source) and 
ammonium ion (the sole nitrogen source). A pH indicator, Bromothymol Blue is also 
included Bromothymol Blue is GREEN at pH < 7.0 and BLUE at pH > 7.6 organisms 
that utilize citrate for energy produce alkaline compounds as by-products. Thus, a 
positive result for citrate utilization is the formation of a BLUE color. This test is among 
a suite of tests (Indole, Methyl-Red, Vogues-Proskauer, and Citrate) that are used to 
differentiate among the Gram-Negative bacilli in the family Enterobacteriaceae. 
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Table 1: The biochemical tests for identification of S. Typhi and S.Paratyphi 
 
Organisms Glucose H2S Motility Indole Urease Citrate 
S.Typhi 
S.Paratyphi A 
S.Paratyphi B 
A + + - - - 
AG - + - - - 
AG + + - - + 
 
Here, 
A means Acid and AG means Acid plus Gas. 
 
2.7.1.3 Antimicrobial sensitivity test 
Antibiotic sensitivity is the susceptibility test of bacteria to antibiotic. This test is usually 
carried out to determine which antibiotic will be most successful in treating a bacterial 
infection in vivo. The antimicrobial sensitivity test was done by “Kirby-Bauer Method”. 
If the bacteria were sensitive to the antibiotic, a clear ring or Zone of inhibition was seen 
around wafer indicating poor growth. 
The following antibiotics and their concentration per disc were used: 
 
 Ampicillin (AMP, 10g) 
 Chloramphenicol (C, 20g) 
 Trimethoprim – Sulphamethoxazol (TS, 23.75g) 
 Ciprofloaxcin (CIP, 5g) 
 Ceftriaxone (CRO , 30g) 
 Nalidixic acid (NA, 30g) 
 Cefixime (CFM, 5g) 
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Figure 20: Method of Sensitivity Test 
 
2.7.1.3.1 Measurement of inhibition zone: 
Antibiotic sensitivity testing is used to determine the susceptibility of bacteria to an 
antibiotic. Numerous standardized tests are available to measure the effectiveness of an 
antibiotic against a specific organism in order to prescribe the most suitable antibiotic 
therapy. Kirby-Bauer Method is one of them. It is very quick an easy method for 
evaluating the numerous antibiotics at once. First the antibiotic disks were placed on a 
plate. Then the plates were incubated to allow growth of the bacteria and time for the 
antibiotics to diffuse into the agar. If an organism was susceptible to an antibiotic, a clear 
zone was appeared around the disk where the growth inhibited. The size of this zone of 
inhibition depends on the sensitivity of the bacteria to the specific antibiotic and the 
antibiotic’s ability also to diffuse through the agar. 
The zone of inhibition was measured by the following way: 
1) Scale 
2) Slide Calipers 
49 
 
 
Figure 21: Zone of Inhibition 
 
2.7.1.4 Separation of plasma and Peripheral Blood Mononuclear Cell 
(PBMC) 
Peripheral blood mononuclear cells (PBMCs) and plasma were isolated from venous 
blood by density gradient centrifugation on Ficoll Isopaque and lymphocyte culture 
supernatant was prepared from the isolated PBMCs. 
 
Procedure: 
  Heparinized venous blood was diluted with equal volume of phosphate buffer 
saline (PBS) in falcon tubes.  
  Ficoll-Isopaque was taken in falcon tube and diluted blood was carefully layered 
on top of it. 
 The tube was centrifuged at 1800 rpm (772xg) for 25 minute at 20c. 
 After centrifugation, there were following four layers- at first a pallet of RBCs 
and granulocytes, second layer was for the Ficoll-Isopaque. PBMCs were in the 
third layer and plasma was in the upper-most fourth layer. 
Antibiotic Disk 
Zone of Inhibition 
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 The plasma was carefully removed from the top with a Pasteur pipette and then 
PBMCs were removed from the top of the Ficoll layer similarly. 
 The PBMCs were washed once in PBS at 2000rpm (953xg) for 10 minute at 
20C. 
 Then they were resuspended in 10 ml of PBS and counted in a hemocytometer. 
 Again it was washed at 2000rpm (953xg) for 10 minute at 20C. 
 
 
 
 
Figure 22:  Separation of plasma and peripheral blood mononuclear cells (PBMC) 
 
 
 
Plasma 
PBMC 
Ficoll Isopaque 
Red Cells, Granulocytes 
and Platelets 
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Preparation of lymphocyte culture supernatant: 
From the isolated PBMC, lymphocyte culture supernatant was prepared in the following 
method used in different studied. 
 The isolated PBMCs were taken and resuspended in RPMI- complete medium to 
a concentration of 1×107 cells per ml medium. 
 The cells were cultured in tissue culture plates (Nunc Coaster) at 37°C in 5% CO2 
incubator for 48 h. 
 After 48 hrs the culture supernatant was taken in an eppendorf and centrifuged at 
12000 rpm (11600xg) at 4°C for 5 minute. 
 The supernatant was removed and then protease inhibitor was added at a 
concentration of 1% of culture supernatant and stored at -70°C for future analysis. 
 
2.7.1.5 Separation of PBMC using lysing solution 
 
 Heparinized venous blood was diluted with 1x Lysing Solution (1:10 dilution) 
and mixes it well gently by inverting the falcon tube. 
 Then incubated the falcon tube for 5 min in room temperature. 
 The tube was centrifuged at 953g for 10 min at 20C. 
 After centrifugation the supernatant was decant quickly and then resuspended the 
cells in 10 ml ice cold PBS. 
 Then cell was counted in a haemocytometer. 
 Again the cell suspension was centrifuged at 953g for 10 min at 20C. 
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Figure 23: Separation of PBMC using Lysing Solution 
 
Preparation of lymphocyte culture supernatant: 
From the isolated PBMC, lymphocyte culture supernatant was prepared in the following 
method used in different studied. 
 The isolated PBMCs were taken and resuspended in RPMI- complete medium 
to a concentration of 1×107 cells per ml medium. 
 The cells were cultured in tissue culture plates (Nunc Coaster) at 37°C in 5% 
CO2 incubator for 48 h. 
 After 48 hrs the culture supernatant was taken in an eppendorf and centrifuged 
at 12000 rpm (11600xg) at 4°C for 5 minute. 
 The supernatant was removed and then protease inhibitor was added at a 
concentration of 1% of culture supernatant and stored at -70°C for future 
analysis. 
RBC Lysis 
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2.7.1.6 Assay of antibody response in lymphocyte secretion, plasma by kinetic 
ELISA 
Enzyme linked immune-sorbant assay (ELISA) is a process of measuring the 
concentration of antigen or antibody. In this process, the antigen is coated in a solid 
surface. Upon administration of antibody containing sample, antibody binds to the 
antigen, which is then detected by binding to another antibody conjugated to an enzyme. 
When substrate is given the enzyme converts it into a colored product. The concentration 
of color is proportional to the concentration of sample antibody.  
The IgA antibody response in lymphocyte culture supernatant against Ty21a Membrane 
Preparation (MP) was measured > 10 ELISA unit was considered as positive result for 
TPTest method. The cut-off value of the TPTest method was calculated by using the 
formula: > 2SD plus geometric mean of healthy Bangladeshi control. 
Procedure: 
Coating of ELISA plate with antigen: 
 MP antigen prepared from Ty21 which was diluted with PBS at a concentration of 
5.0 g/ml for lymphocyte culture supernatant.  
 ELISA-plates (NuncF) were coated with 100 l/well of antigen suspension. 
 The plates were incubated at room temperature for overnight. 
Blocking: 
 The coated plates were washed thrice with PBS. 
 The plates were blocked with 200 l/well of 1% bovine serum albumin in PBS 
(BSA-PBS) and incubated for 30 minutes at 37°C. 
Sample loading: 
 The plates were washed three times with PBS-Tween (0.05% Tween) and once 
with PBS. 
 ALS samples were diluted at 1:2 dilutions.  
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 For positive control, pooled plasma of typhoid positive patients was taken and 
diluted with 0.1% BSA-PBS-Tween and 100µl of diluted pool solution was given 
in appropriate well.                         
 For determining antibody response in ALS, pooled plasma was diluted at 1:100 
dilutions. 
 For negative control, 100µl 0.1% BSA-PBS-Tween was given in appropriate 
wells. 
 The plates were then incubated at room temperature for 90 minutes. 
 
Conjugate adding: 
 The plates were washed three times with PBS-Tween (0.05% Tween) and once 
with PBS. 
 For ALS, the rabbit anti-human IgA, conjugated with horse reddish peroxidase 
were diluted in 0.1% BSA-PBS-Tween at 1:1000 dilutions and 100 µl was added 
in each well. The plates were incubated at room temperature for 90 minutes. 
 
Plate developing: 
 The plates were washed three times with PBS-Tween (0.05% Tween) and once 
with PBS. 
 The substrate- H2O2-OPD was made by dissolving 10 mg OPD 
(orthophenyldiamine) in 10 ml of  0.1M sodium citrate buffer ( pH 4.5), to which 
4 µl of 30% H2O2 was added immediately before use. 
 The plates were developed by adding H2O2-OPD at 100 µl in each well. 
 Then optical density (O.D.) was measured at 450 nm by the Multiskan Ascent 
ELISA reader in kinetic mode immediately. 
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2.7.1.7 Immunodot blot assay 
Immunodot blot assay is another method for detecting the antibody response. This 
method is simplified in comparison to ELISA. 
 
2.7.1.7.1 Immunodot blot assay detection of antibodies in lymphocyte 
secretion separated by ficoll method 
 
2.7.1.7.1.1 Immunodot blot assay for rabbit anti-human IgA conjugate with 
HRP and 4-Chloro-1 –Napthol (4CN) substrate 
Procedure:  
 The strips were divided of 30630cm Osmonics NitroBind 0.45mm Transfer 
Membrane into 0.35 by 0.35 cm squares. 
 Then soaked these strips in PBS and allowed the membranes to dry before coating 
them with MP antigen (1 and 1.5 mg/ml MP antigen) dissolved in PBS, 
AffinePure Goat Anti-human IgG, F (ab
/
)2 Fragment (1.2 mg/ml dissolved in 
deionized water) as a positive control and Lipopolysaccharide (LPS) of Vibrio 
cholerae O1 X-25049 strain (Ogawa) (0.5 mg/ml dissolved in PBS) as a negative 
control at room temperature. 
 1 µl of antigen added each well. 
 Then kept it at room temperature for 5 minutes. 
 Then blocked the membranes with 1% bovine serum albumin in PBS at room 
temperature for 30 minutes using slow shaking (230 rpm; Gyrotory Water Bath 
Shaker; New Brunsick Scientific). 
 After 30 minutes discarded the blocking solution and washed the membrane twice 
with PBS. 
 To assess immuno-reactivity, added lymphocyte culture supernatants diluted 1:2 
with 0.1% BSA-PBS -0.05% Tween to membrane. 
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 Then incubated these for 3 hours at room temperature with slow shaking (230 
rpm; Gyrotory Water Bath Shaker; New Brunsick Scientific). 
 After 3 hours incubation, washed the membranes 5 times with PBS-Tween 
(0.05%) and once with PBS. 
 Then incubated the membranes with rabbit anti-human IgA conjugated to horse 
radish peroxidase (Jackson Immunoresearch Laboratories, Inc. West Grove. USA 
at a 1:500 dilution in 0.1% BSA-PBS-Tween) for 1.5 hours at room temperature 
with shaking. 
 After that washed the membrane five times with PBS-Tween (0.05%) and once 
with PBS. 
 Then developed the membranes by adding H2O2 4-Chloro-1-napthol, prepared by 
dissolving 1.7 ml 4-Chloro-1-Napthol (3 mg/ml in 99.9% methanol) in 8.3 ml of 
Tris buffered saline (TBS; 20 mM Tris; 0.5 M Nacl; pH-7.5) and 10 µl H2O2. 
 H2O2 was added immediately before use. 
 The reactivity was read at 5 minutes. 
 Then membranes were washed with tap water and air dried. 
 After that immunodots positive considered when reactivity was seen with nacked 
eye after membranes had dried. 
 Dots were independently read with 100% concordance.  
 
2.7.1.7.1.2 Immunodot blot assay for biotinylated IgA conjugate with 
streptavidin HRP and 3, 3/-Diaminobenzidine (DAB) Substrate: 
Procedure: 
 The strips were divided of 30630cm Osmonics NitroBind 0.45mm Transfer 
Membrane into 0.35 by 0.35 cm squares. 
 Then soaked these strips in PBS and allowed the membranes to dry before coating 
them with MP antigen (1 and 1.5 mg/ml MP antigen) dissolved in PBS, 
AffinePure Goat Anti-human IgG, F (ab
/
)2 Fragment (1.2 mg/ml dissolved in 
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deionized water) as a positive control and Lipopolysaccharide (LPS) of Vibrio 
cholerae O1 X-25049 strain (Ogawa) (0.5 mg/ml dissolved in PBS) as a negative 
control at room temperature. 
 1 µl of antigen added each well. 
 Then kept it at room temperature for 5 minutes. 
 Then blocked the membranes with 1% bovine serum albumin in PBS at room 
temperature for 30 minutes using slow shaking (230 rpm; Gyrotory Water Bath 
Shaker; New Brunsick Scientific). 
 After 30 minutes discarded the blocking solution and washed the membrane twice 
with PBS. 
 To assess immuno-reactivity, added lymphocyte culture supernatants diluted 1:2 
with 0.1% BSA-PBS -0.05% Tween to membrane. 
 Then incubated these for 3 hours at room temperature with slow shaking (230 
rpm; Gyrotory Water Bath Shaker; New Brunsick Scientific). 
 After 3 hours incubation, washed the membranes 5 times with PBS-Tween 
(0.05%) and once with PBS. 
 Then incubated the membranes with Biotinylated IgA conjugate (1:500 dilution in 
0.1% BSA-PBS-Tween) for 1.15 hours at room temperature with slow shaking. 
 After incubation washed the membrane one times with PBS-Tween (0.05%) and 
once with PBS. 
 Then incubated the membrane with Streptavidin HRP (1:100 dilution in 0.1% 
BSA-PBS-Tween) for 45 minutes with slow shaking. 
 After that washed the membrane three times with PBS-Tween (0.05%) and once 
with PBS. 
 Then developed the membrane by adding 4 ml of PBS, 0.002 gm DAB and 6 µl 
H2O2. 
 H2O2 was added immediately before use. 
 The reactivity was read at 5 minutes. 
 Then membranes were washed with tap water and air dried. 
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 After that immunodots positive considered when reactivity was seen with nacked 
eye after membranes had dried. 
 Dots were independently read with 100% concordance.  
 
2.7.1.7.1.3 Immunodot blot assay for biotinylated IgA conjugate with 
streptavidin HRP and 3, 3/, 5, 5/-Tetramethylbenzidine (TMB) substrate: 
Procedure: 
 The strips were divided of 30630cm Osmonics NitroBind 0.45mm Transfer 
Membrane into 0.35 by 0.35 cm squares. 
 Then soaked these strips in PBS and allowed the membranes to dry before coating 
them with MP antigen (1 and 1.5 mg/ml MP antigen) dissolved in PBS, 
AffinePure Goat Anti-human IgG, F (ab
/
)2 Fragment (1.2 mg/ml dissolved in 
deionized water) as a positive control and Lipopolysaccharide (LPS) of Vibrio 
cholerae O1 X-25049 strain (Ogawa) (0.5 mg/ml dissolved in PBS) as a negative 
control at room temperature. 
 1 µl of antigen added each well. 
 Then kept it at room temperature for 5 minutes. 
 Then blocked the membranes with 1% bovine serum albumin in PBS at room 
temperature for 30 minutes using slow shaking (230 rpm; Gyrotory Water Bath 
Shaker; New Brunsick Scientific). 
 After 30 minutes discarded the blocking solution and washed the membrane twice 
with PBS. 
 To assess immuno-reactivity, added lymphocyte culture supernatants diluted 1:2 
with 0.1% BSA-PBS -0.05% Tween to membrane. 
 Then incubated these for 3 hours at room temperature with slow shaking (230 
rpm; Gyrotory Water Bath Shaker; New Brunsick Scientific). 
 After 3 hours incubation, washed the membranes 5 times with PBS-Tween 
(0.05%) and once with PBS. 
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 Then incubated the membranes with Biotinylated IgA conjugate (1:500 dilutions 
in 0.1% BSA-PBS-Tween) for 1.15 hours at room temperature with slow shaking. 
 After incubation washed the membrane one times with PBS-Tween (0.05%) and 
once with PBS. 
 Then incubated the membrane with Streptavidin HRP (1:100 dilution in 0.1% 
BSA-PBS-Tween) for 45 minutes with slow shaking. 
 After that washed the membrane three times with PBS-Tween (0.05%) and once 
with PBS. 
 Then developed the membrane by adding 2.5 ml deionized water, 2.5 ml Na-
acetate, 25 µl Citric acid, 50 µl TMB and 0.6 µl H2O2. 
 TMB and H2O2 were added immediately before use. 
 The reactivity was read at 5 minutes. 
 Then membranes were washed with tap water and air dried. 
 After that immunodots positive considered when reactivity was seen with nacked 
eye after membranes had dried. 
 Dots were independently read with 100% concordance. 
 
2.7.1.7.2 Immunodot blot assay for detection of antibodies in lymphocyte 
secretion separated by RBC lysis method 
2.7.1.7.2.1 Immunodot blot assay for RBC lysis with 5% CO2 : 
Procedure: 
 The strips were divided of 30630cm Osmonics NitroBind 0.45mm Transfer 
Membrane into 0.35 by 0.35 cm squares. 
 Then soaked these strips in PBS and allowed the membranes to dry before coating 
them with MP antigen (1.5 mg/ml MP antigen) dissolved in PBS, AffinePure 
Goat Anti-human IgG, F (ab
/
)2 Fragment (1.2 mg/ml dissolved in deionized water) 
as a positive control and Lipopolysaccharide (LPS) of Vibrio cholerae O1 X-
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25049 strain (Ogawa) (0.5 mg/ml dissolved in PBS) as a negative control at room 
temperature. 
 1 µl of antigen added each well. 
 Then kept it at room temperature for 5 minutes. 
 Then blocked the membranes with 1% bovine serum albumin in PBS at room 
temperature for 30 minutes using slow shaking (230 rpm; Gyrotory Water Bath 
Shaker; New Brunsick Scientific). 
 After 30 minutes discarded the blocking solution and washed the membrane twice 
with PBS. 
 To assess immuno-reactivity, added lymphocyte culture supernatants diluted 1:2 
with 0.1% BSA-PBS -0.05% Tween to membrane. 
 Then incubated these for 3 hours at room temperature with slow shaking (230 
rpm; Gyrotory Water Bath Shaker; New Brunsick Scientific). 
 After 3 hours incubation, washed the membranes 5 times with PBS-Tween 
(0.05%) and once with PBS. 
 Then incubated the membranes with rabbit anti human IgA conjugated to horse 
radish peroxidase (Jackson Immunoresearch Laboratories, Inc. West Grove. USA 
at a 1:500 dilution in 0.1% BSA-PBS-Tween) for 1.5 hours at room temperature 
with shaking. 
 After that washed the membrane five times with PBS-Tween (0.05%) and once 
with PBS. 
 Then developed the membranes by adding H2O2 -4-Chloro-1-napthol, prepared by 
dissolving 1.7 ml 4-Chloro-1-Napthol (3 mg/ml in 99.9% methanol) in 8.3 ml of 
Tris buffered saline (TBS; 20 mM Tris; 0.5 M Nacl; pH-7.5) and 10 µl H2O2. 
 H2O2 was added immediately before use. 
 The reactivity was read at 5 minutes. 
 Then membranes were washed with tap water and air dried. 
 After that immunodots positive considered when reactivity was seen with nacked 
eye after membranes had dried. 
 Dots were independently read with 100% concordance.   
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2.7.1.7.2.2 Immunodot blot assay for RBC lysis without 5% CO2 : 
Procedure: 
 The strips were divided of 30630cm Osmonics NitroBind 0.45mm Transfer 
Membrane into 0.35 by 0.35 cm squares. 
 Then soaked these strips in PBS and allowed the membranes to dry before coating 
them with MP antigen (0.5 mg/ml, 1 mg/ml and 1.5 mg/ml MP antigen) dissolved 
in PBS, AffinePure Goat Anti-human IgG, F (ab
/
)2 Fragment (1.2 mg/ml 
dissolved in deionized water) as a positive control and Lipopolysaccharide (LPS) 
of Vibrio cholerae O1 X-25049 strain (Ogawa) (0.5 mg/ml dissolved in PBS) as a 
negative control at room temperature. 
 1 µl of antigen added each well. 
 Then kept it at room temperature for 5 minutes. 
 Then blocked the membranes with 1% bovine serum albumin in PBS at room 
temperature for 30 minutes using slow shaking (230 rpm; Gyrotory Water Bath 
Shaker; New Brunsick Scientific). 
 After 30 minutes discarded the blocking solution and washed the membrane twice 
with PBS. 
 To assess immuno-reactivity, added lymphocyte culture supernatants diluted 1:2 
with 0.1% BSA-PBS -0.05% Tween to membrane. 
 Then incubated these for 3 hours at room temperature with slow shaking (230 
rpm; Gyrotory Water Bath Shaker; New Brunsick Scientific). 
 After 3 hours incubation, washed the membranes 5 times with PBS-Tween 
(0.05%) and once with PBS. 
 Then incubated the membranes with rabbit anti human IgA conjugated to horse 
radish peroxidase (Jackson Immunoresearch Laboratories, Inc. West Grove. USA 
at a 1:500 dilution in 0.1% BSA-PBS-Tween) for 1.5 hours at room temperature 
with shaking. 
 After that washed the membrane five times with PBS-Tween (0.05%) and once 
with PBS. 
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 Then developed the membranes by adding H2O2 -4-Chloro-1-napthol, prepared by 
dissolving 1.7 ml 4-Chloro-1-Napthol (3 mg/ml in 99.9% methanol) in 8.3 ml of 
Tris buffered saline (TBS; 20 mM Tris; 0.5 M Nacl; pH-7.5) and 10 µl H2O2. 
 H2O2 was added immediately before use. 
 The reactivity was read at 5 minutes. 
 Then membranes were washed with tap water and air dried. 
 After that immunodots positive considered when reactivity was seen with nacked 
eye after membranes had dried. 
 Dots were independently read with 100% concordance.   
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Results 
3.1. Study participants 
For optimization and evaluation of the immunodot blot assay, specimens from 107 
patients were tested. Among them 46 patients were bacteremic with S. Typhi infection 
and 36 were blood culture negative but TPTest positive. . The immunodot blot assay was 
also tested in 23 healthy controls and 6 kala-azar and 6 tuberculosis patients. Patients 
with Kala-azar and tuberculosis were tested as controls with other febrile illnesses to rule 
out cross reactions. 
The participants of the study were categorized into five groups for data analysis and for 
optimization of the immunodot blot assay. 
 
Table 2: Grouping of the study participants 
Groups Number of the participants 
Blood culture positive and TPTest  positive 46 
Blood culture negative and TPTest  
positive 
36 
Blood culture negative and TPTest 
negative 
25 
Healthy controls 23 
Other febrile diseases 12 
Total 142 
 
3.2 Baseline data of the participants 
Among 107 typhoid fever (blood culture positive and only TPTest positive) patients, 60 
(56.07%) were male and 47 (43.92%) were female. The median age of the patients was 7 
years 8 months, with a range of 1 to 44 years.  
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Table 3: Baseline data of the patients with febrile illness (n=107) 
Features Value 
Median age in year (25th, 75th percentile) 7.8 (5.4, 18) 
No. of males (%) 60 (56.07%) 
No. of females (%) 47 (43.92%) 
Median temperature in °C (25th, 75th 
percentile) 
39.2 (39.1, 39.5) 
Duration of fever in days at presentation 
(25th, 75th percentile) 
4 (3, 5) 
 
No. of patients with serovar Typhi in blood 
(%) 
35 (40.7%) 
 
Median pulse/min (25th, 75th percentile) 92.5 (83.5, 97.5) 
 
3.3 Clinical findings of participants 
The patients presented with the complaints of headache, abdominal pain, constipation, 
coated tongue, diarrhea, vomiting, rose spot and rash. 
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Table 4: Clinical findings of the participants (n=107) 
Clinical Features Number (%) 
No. of patients (%) with:  
Headache 70 (81.4) 
Abdominal pain 51 (55.4) 
Constipation 28 (30.4) 
Coated tongue 47(51.1) 
Diarrhea 12 (13) 
Vomiting 15 (17.44) 
Rose spot 8 (9.3) 
Rash 8 (9) 
 
3.4 Blood culture and sensitivity result 
Among 46 S. Typhi bacteremic patients, 25 were male (54.34%) and 21 were female 
(45.64%). Of 46 isolated S. Typhi strains, all (100%) were sensitive to cefixime, 
ceftriaxone and 11 (31%) were resistant to ampicillin, 15 (53.57%) were resistant to 
trimethoprim-sulfamethoxazole, 17 (60.71%) were resistant to chloramphenicol, 9 
(32.14%) were resistant to ciproﬂoxacin and 27 (92.86%) were resistant to nalidixic acid. 
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Table 5: Antibiotic susceptibility pattern of isolated S. Typhi (n=46) 
Antibiotic Sensitive (%) Resistant (%) 
Ceftriaxone 28 (100) 0 (0.00) 
Cefixim 28 (100) 0 (0.00) 
Ciprofloxacin 9 (67.86) 9 (32.14) 
Ampicillin 21 (60) 11 ( 31) 
Chloramphenicol 11 (39.29) 17 (60.71) 
Trimethoprim-
sulphamethoxazole 
26 (30) 15 (53.57) 
Nalidixic acid 2 (7.14) 27 (92.86) 
 
 
3.5. Comparison of the result of immunodot blot assay with the standard 
TPTest 
Three types of substrates (4CN: 4-Chloro-1-Napthol, DAB: 3, 3/-Diaminobenzidine, and 
TMB: 3, 3/, 5, 5/-Tetramethylbenzidine) were used for immunodot blot assay and results 
were compared with the TPTest. Three TPTest positive (12.32 EU, 14.08 EU and 13.6 
EU) specimens were tested with three types of substrates for immunodot blot assay. 
Among three substrates, the intensity of the spot was higher when they tested with TMB 
and 4-CN was than DAB. Thereafter 4-CN and TMB were used for further analysis. 
 
 
 
 
 
 
 Figure 24: Comparison of the immunodot blot assay with TPTest pos
A. TPTest result: 12.32 EU
 
 
B.TPTest result: 14.08 EU
                       
 
 
Substrate: 4-CN 
 
Substrate: 4-CN 
 
itive specimens 
among three types of substrates 
 
                  
 
                       
Substrate: DAB 
 
Substrate: TMB
 
Substrate: DAB
  
Substrate: TMB
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 C.TPTest result: 13.6 EU
 
 
3.6 Results of the immunodot blot assay using different concentrations of 
antigen:  
With1.5 mg/ml membrane preparation (MP) antigen:
To detect  the TPTest positive (cut
technique and to increase the intensity of the spots, t
preparation (MP) antigen (
increased (from 0.5 µl/ml to 1 µl/ml).
concentration of antigen and increased amount of 
categories of patients: 
 
 
 
 
Substrate: 4
 
                              
                          
 
-off value: >10 EU) specimens by the immunodot blot 
he concentration of the membrane 
from 1 mg/ml to 1.5 mg/ml) and the amount of 
 The immunodot blot assay with increased 
H2O2 was carried out in different 
-CN Substrate: DAB
  
Substrate: TMB
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H2O2 were 
 
 i. Blood culture and TPTest positive:
 All patients positive for blood culture 
 
 
 
 
ii. Blood culture negative and TPTest positive:
    All blood culture negative 
assay. 
 
 
Test-Blood culture positive and TPTest 
positive (n=09)
01:12.06 EU; 02:11.15 EU
and 03=13.45 EU
Substrate: 4
Test-Blood culture n
TPTest positive (n=04)
01:12.32 EU and 02:13.08 EU
Substrate: 4
 
positive were detected by dot blot assay.
                
 
and TPTest positive specimens were detected by the dot blot 
            
 
 
 
-CN 
Test-Blood culture positive and TPTest 
positive (n=06)
01:13 EU; 02:12 EU; 03:11 EU and 04:15 EU
Substrate: TMB
egative and 
 
 
-CN 
Test-Blood culture negative and TPTest
positive (n=04) 
01: 13 EU, 02: 12 EU and 03: 11 EU
Substrate: TMB 
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 iii. Blood culture negative and TPTest negative:
No colored dots were seen in blood culture negative and TPTest negative specimens 
using 4-CN. But dots were 
using TMB. 
 
 
 
 
 
Test-Blood culture negative and TPTest n
01: 8.0 EU; 02:1.0 EU; 03: 8.2 EU; 04:8.0 EU;05:4.0 EU; 
Test-Blood culture n
01: 8.0 EU; 02: 1.0 EU; 03: 8.2 EU; 
 
visualized in blood culture negative and TPTest negative 
 
 
egative (n=14) 
06:9.36 EU and 07:9.57 EU 
Substrate: 4-CN 
egative and TPTest negative (n=14) 
04:8.0 EU; 05: 4.0 EU, 06: 
9.36 EU, 07: 9.57 EU and 08: 1.12 EU 
Substrate: TMB 
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 iv. Healthy control: 
No dots were found in healthy control using 4
control using TMB.  
  
 
 
-CN. But dots were found in healthy 
 
 
Substrate: TMB 
 
Test-Healthy Control (n=12) 
Substrate: 4-CN 
Test-Healthy Control 
(n=12) 
Substrate: TMB 
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 v. Other febrile diseases:
No dots were visualized in
in other febrile diseases using TMB. 
Thus use TMB appeared 
specimens. But it had also 
healthy control and other febrile illness. 
The use of 4-CN showed positive results in TPTest positive specimens and negative 
results in negative specimens, healthy control and other febrile illness. Hence 4
taken for further analysis.
 
 
 other febrile diseases using 4-CN. But dots
 
 
 
 
to be more sensitive and gave positive results in TPTest positive 
showed positive results in negative specimens as well as 
 
 
Test-Other febrile illness (n=12) 
Substrate: 4-CN 
Test-Other febrile illness (n=12) 
Substrate: TMB 
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 were found 
 
-CN had 
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Summary of the results: 
Table 6: Comparison of results between TPTest method and immunodot blot assay 
(Using 4-CN Substrate) 
Patient Categories TPTest Method Immunodot Blot Assay 
 Positive Negative Positive Negative 
Blood culture positive and 
TPTest positive (n=09) 
09 0 09 0 
Blood culture negative and 
TPTest positive (n=04) 
04 0 04 0 
Blood culture negative and 
TPTest negative (n=14) 
0 14 0 14 
Healthy control (n=12) 0 12 0 12 
Other febrile diseases 
(n=12) 
0 12 0 12 
 
Table 7: Comparison of results between TPTest method and immunodot blot assay 
(Using TMB Substrate) 
Patient Categories TPTest Method Immunodot Blot Assay 
 Positive Negative Positive Negative 
Blood culture positive and 
TPTest positive (n=06) 
06 0 06 0 
Blood culture negative and 
TPTest positive (n=04) 
04 0 04 0 
Blood culture negative and 
TPTest negative (n=14) 
0 14 14 0 
Healthy control (n=12) 0 12 12 0 
Other febrile diseases 
(n=12) 
0 12 12 0 
 Samples were further analyzed 
convalescence) and Day 21 (late convalescence).
their TPTest results.  
 Low values (11-16 EU)
 Medium values (20
 High values (70 and above)
Low values (11-16 EU): 
In this category total samples were 30 in which 28 cases (93.3
Immunodot blot assay but 30 cases (100%) 
(6.7%) were negative by Immunodot blot assay.
 
01: 15 EU; 02: 13.63 EU; 03:12.08 EU; 04:16 EU; 05:12.32 EU; 06= 15
at three different time points- Day 
 Samples were categorized according to 
 
- 70 EU) 
 
 
%) were positive by 
positive by TPTest method. Only 2 cases 
 
 
 
 EU, 
07= 13 EU and 08= 11 EU 
04:16 EU; 05:12.7 EU and 06:14.35 EU 
75 
0, Day 7 (early 
 
 Table 8: Comparison of results
Patient Categories
 
Blood culture positive and 
TPTest positive (n=15)
Blood culture negative and 
TPTest positive (n=15)
Total samples (n=30)
 
Medium values (20- 70 EU)
In this category total samples were 16 in which 16 cases (100%) were positive by 
method and Immunodot blot assay.
01=33 EU, 02=22 EU, 03=26 EU, 04=39 EU, 05=41.55 EU and 06=48.91 
 between TPTest method and immunodot blot assay 
(Low values) 
 TPTest Method Immunodot Blot 
Positive Negative 
 
15 0 
 
15 0 
   
: 
 
 
 
 
EU 
 
76 
Assay 
Positive Negati
ve 
15 0 
13 0 
  
TPTest 
 
 Table 9: Comparison of results
Patient Categories
 
Blood culture positive and 
TPTest positive (n=09)
Blood culture negative and 
TPTest positive (n=07)
Total samples (n=16)
 
High Values (≥70 EU): 
In this category total samples were 10 in which 10 cases (100%) were positive by 
the TPTest method and Immunodot blot assay.
 
 
01= 109 EU, 02=196.88 EU and 03=148.6 EU
 between TPTest method and immunodot blot assay 
(Medium values) 
 TPTest Method Immunodot Blot Assay
Positive Negative Positive
 
09 0 
 
07 0 
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 Negative 
09 0 
07 0 
  
both 
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Table 10: Comparison of results between TPTest method and immunodot blot assay 
(High values) 
Patient Categories TPTest Method Immunodot Blot Assay 
 Positive Negative Positive Negative 
Blood culture positive and 
TPTest positive (n=07) 
07 0 07 0 
Blood culture negative and 
TPTest positive (n=03) 
03 0 03 0 
Total samples (n=10)     
 
Table 11: Summary of the results 
Patient Categories (According to 
their ELISA Unit) 
Positive Negative 
Low values (n=30) 28 02 
Medium values (n=16) 16 0 
High values (n=10) 10 0 
 
3.7 Results of the immunodot blot assay using specimens prepared by RBC 
lysis:  
The isolated cells from 13 patients and 11 healthy controls by the RBC lysis procedure 
were incubated at 37oC with 5% CO2 supply and with no CO2 supply.  After incubation, 
the cell culture supernatant was tested by dot blot assay.  
 
 
 3.7.1 Results of immunodot blot assay
with 5% CO2  
The specimen prepared by RBC lysis with 5% CO
with a concentration of MP (1.5 mg/ml) antigen.
i. Blood culture and TPTest positive:
 
All blood culture and TPTest positive were detected by dot blot assay.
 
 using specimens prepared by RBC lysis 
2 was tested by immunodot blot assay 
 
 
   
 
                                          
 
 
 
 
 
 
Blood culture positive and TPTest positive 
(n=02) 
04: EU=32.2 
Substrate: 4-CN 
 
79 
 
 ii. Blood culture negative and TPTest positive:
All blood culture negative and TPTest positive were detected by dot blot assay.
   Blood culture 
 
iii. Blood culture negative and TPTest negative:
All blood culture negative and TPTest negative also showed positve results by dot blot 
assay. 
 
 
Blood culture 
01= 10.21 EU, 02=5.95 EU, 03= 8.51 EU, 04= 
 
       
negative and TPTest positive (n=01) 
01: 65.57 EU 
 
 
negative and TPTest negative (n=08) 
1.8 EU and 
05=1.6 EU 
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 3.7.2 Results of immunodot blot assay
with no CO2  
The specimen prepared by RBC lysis with no CO
with a concentration of MP (1.5 mg/ml) antigen. 
i. Blood culture and TPTest positive:
 
All blood culture and TPTest positive were detected by dot blot assay.
 
 
 
 
 
 
 
Blood culture positive and TPTest p
01= 21.46 EU, 02= 103.39 EU, 03= 75.14 EU and 
 using specimens prepared by RBC lysis 
2 was tested by immunodot blot assay 
 
 
                     
 
 
ositive 
(n=04) 
04=168.93 EU 
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 ii. Blood culture negative and TPTest positive:
All blood culture negative 
 
Blood culture 
iii. Blood culture negative and TPTest negative:
All blood culture negative 
blot assay. 
 
and TPTest positive were detected by dot blot assay.
 
negative and TPTest positive (n=01) 
02: 81.04 EU 
 
 
and TPTest negative also showed positve results by dot 
 
 
 
Blood culture negative and TPTest negative 
01=4.30 EU, 02=3.86 EU and 03=3.02 EU 
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 iv. Healthy control: 
All healthy control
The specimen prepared by RBC lysis with no CO
with a concentration of MP (0.5 mg/ml) antigen. 
 Healthy control: 
All healthy control (n=11)
 also showed positve results by dot blot assay. 
 
 
2 was tested by immunodot blot assay 
 
 also showed positve results by dot blot assay.
 
Healthy control (n=11) 
 
 
 
Healthy control (n=11) 
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The specimen prepared by RBC lysis with no CO2 was tested by immunodot blot assay 
with a concentration of MP (1 mg/ml) antigen.  
 Healthy control: 
All healthy controls (n=11) also showed positve results by dot blot assay. 
 
Healthy control (n=11) 
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Discussion 
Typhoid fever is perceived as a major cause of morbidity worldwide [4] [95]. In 
Bangladesh, it occurs as an endemic disease [96]. Clinical diagnosis of typhoid fever is 
difficult because the symptoms of typhoid fever mimic other febrile diseases [97]. 
Isolation of Salmonella enterica serovar Typhi from bone marrow culture is the gold 
standard of diagnosis of an infection but it is an invasive method and improbable in 
resource limited condition. It is also clinically impractical method due to hazardous 
procedure and technical expert and well equipped laboratory are needed to isolate 
pathogen from bone marrow [89]. Blood culture has low sensitivity. The sensitivity of 
blood culture test also is only around 30-50% [6]. Large volume of blood is needed for 
culture (3 ml for children and 5 ml for adults) and it also takes at least three days to 
obtain a result [98] [99]. The TPTest is a diagnostic method for early diagnosis of typhoid 
and paratyphoid (enteric) fever. From the venous blood of the patients, the lymphocytes 
that have been recovered are primed and derived from the gut mucosa and are transiently 
circulating in the peripheral circulation and IgA antibodies represent markers of recent 
infection in the gut to membrane preparation (MP) antigen of S. Typhi [93, 100]. The 
sensitivity and specificity of the TPTest are 100% and 78-97% respectively [6]. 
In this study, automated blood culture was used for isolation of the organism and disk 
diffusion method was used for determination of the antibiotic susceptibility pattern of the 
isolated strains of S. Typhi. Antibiogram was carried out with commonly used antibiotics 
and varying susceptibility patterns were observed. Findings uncover that a higher level of 
resistance to first line of antibiotics which may be due to widespread and improper use of 
antibiotic. In this study, among 46 isolated serovar Typhi, 60% were sensitive to 
ampicillin, 30% were sensitive to trimethoprim-sulfamethoxazole, 39.29% sensitive to 
chloramphenicol and 67.86% were sensitive to ciprofloxacin. All the isolated serovar 
Typhi were 100% sensitive to cefixime and ceftriaxone. In this study, 7.14% 
nalidixicacid- resistant Salmonella Typhi (NARST) were isolated. The isolated serovar 
Typhi that are resistant to nalidixic acid (NARST) and susceptible to ciprofloxacin by 
current disk diffusion method, have been proposed as an indicator that such serovar 
Typhi strain may not respond to fluoroquinolone treatment [95].  
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Previous study reported that all blood culture positive typhoid fever patients could be 
identified by the TPTest [6]. Simplification of the TPTest was done at different stages of 
the method, like cell separation method, incubation of the isolated cells with CO2 
supplementation. The immunodot blot assay could not detect positive (cut-off: 10 ELISA 
unit) samples having ≤16 ELISA unit (EU). Hence in this study this method was 
optimized for the detection of positive samples with low values (≤16 EU). 
Previously the immunodot blot assay was used to detect the IgA antibody response in the 
peripheral blood antibodies (PBA) specimens using the ficoll density gradient 
centrifugation and 4-Chloro-1 –Napthol (4CN) Substrate. The concentration for 
membrane preparation (MP) antigen was 1mg/ml. Here in addition to 4CN substrate 3, 3/-
Diaminobenzidine (DAB) and 3, 3/, 5, 5/-Tetramethylbenzidine (TMB) were used to 
increase the intensity of the dot. The dots for positive patients were less prominent with 
DAB than TMB and 4-CN. 
The antigen concentration and the amount of H2O2 were increased for TMB and 4-CN, 
and different categories of the participants were tested. The optimized dot blot assay 
using 4-CN has showed positive result for all blood culture and TPTest positive patients 
and the assay was negative for negative patients and healthy controls and also for the 
patients with other febrile illness (kala-azar and tuberculosis). The optimized dot blot 
assay using TMB has shown less specificity and was positive for all categories of 
participants including negative patients, healthy controls and other febrile illness patients. 
Therefore TMB was not used for further experiments.  
The immunodot blot assay was also carried out with simplified RBC lysis cell separation, 
incubation of the isolated cells at 37oC with and/or without CO2 supply. The specimens 
prepared by RBC lysis procedure give nonspecific results for all categories of the 
participants. The experiment was also carried out with reduced concentration of the MP 
antigen and found the same nonspecific positive dots for negative patients, healthy 
controls and patients with other diseases. Further experiments need to be carried out to 
optimize the simplified dot blot assay using RBC lysis cell separation and incubation of 
cells without CO2 supply.   
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At present, the TPTest positive patients with lower values can be detected by immunodot 
blot assay using density gradient centrifugation without CO2 supplementation. The results 
of this study suggest that the optimized immunodot blot assay will be helpful for 
diagnosis of enteric fever at the laboratories with less facility in endemic region like 
Bangladesh.   
 
The following conclusions can be drawn from the present study: 
i. This study simplified and optimized the TPTest method for the detection of 
positive samples with low values (≤16 EU). 
ii. Addition to 4-Chloro-1-Napthol (4CN) substrate, 3,3/-Diaminobenzidine 
(DAB) and 3, 3/, 5, 5/-Tetramethylbenzidine (TMB) increased the intensity of 
the dots. The dots for positive patients were less prominent with DAB than 
TMB and 4-CN. 
iii. The optimized dot blot assay using 4-CN showed positive results for all blood 
culture and TPTest positive patients and the assay was negative for negative 
patients and healthy controls and also for the patients with other febrile illness 
(kala-azar and tuberculosis). 
 
Recommendations for future work 
The different parameters of the TPTest need further modifications to make it adaptable 
for a rapid test that can be used in field settings and laboratories which lack facilities. 
These include procedures including cell separation techniques, incubation conditions, 
mixing of different substrates to improve the sensitivity of the test and further work in 
this direction will result in a simple, rapid, and effective at the same time sensitive test for 
diagnosis of a dreadful disease like typhoid and paratyphoid fever. 
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Laboratory Apparatus 
 
1. Eppendorf tubes and micropipette tips were taken from Eppendorf® and Sigma, 
and were sterilized by autoclaving at 121°C for 20 minutes.  
2. Petridishes used in the experiments were provided by either Sterilin or Gibco. 
Screw capped tubes and other glass wares were taken from Pyrex® Labware, 
USA.  
3. Plastic tubes and pipettes were of Falcon®; both were the brands of Becton, 
Dickinson and Company. 96-well ELISA plates were obtained from Nunc™, 
Sweden.  
4. Micropipettes were from Thermo Labsystems.  
5. Mini scale centrifugations were carried out in a Sorvall® pico microfuge and 
large-scale centrifugation were carried out in a Sorvall® Legend™ RT super speed 
centrifuge. ELISA reading was taken using ASCENT Multiskan® reader.  
6. Heparin-coated sterile vacutainer tubes (Becton Dickinson, Ruther-ford, NJ) 
7. Multi-channel dispenser (Lab System, USA). 
 
 Chemical Reagents: 
 
1. Ficoll, Pharmacia LKB Biotechnology AB Uppsala, Sweden.  
2. Rabbit anti-human immunoglobulin horseradish peroxidase, Jackson Immuno 
Research, West Grove, P. A., USA. 
3. H2O2 (Hydrogen Peroxide), Fisher Scientific, H-325. 
4. FBS (Foetal Bovine Serum Albumin), Gibco BRL- 16140-071. 
5. Goat Anti Human IgG F(ab)2, Jackson Immuno Research 109-005-097. 
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6. NaCl (Sodium Chloride), Fisher Scientific, Pittsburgh, PA, USA. 
7. KH2P04 (Potassium Phosphate). 
8. Tween 20 (polyoxietylensorbitanmonolaurat), Sigma chemical Co., St. Louis, 
MO, USA 
9. NaCl (Sodium Chloride), Fischer Scientific, Pittsburgh, PA, USA. 
10. Methanol, Merck KGA, Index No-603-001-00-X, Darmstadt, Germany. 
11. Napthol, Index- A8625-25G, Sigma Chemical Co., St. Louis, MO, USA. 
12. DAB, Lot-D 5637-10G, Sigma ALDRICH.Inc. USA. 
13. Na-Acetate, Lot-93H-111-515, Molecular Sigma Biology. 
14. Citric Acid, Lot-705455, Fischer Scientific, New Jersey, USA. 
15. TMB, Lot-SLBC4166V, Sigma ALDRICH.Inc. USA. 
16. Biotin, Lot-3830-4-250, Batch-3, Fischer Scientific, Pittsburgh, PA, USA. 
17. Streptavidin, Lot-3420-2H (mabtech), Batch-73, Fischer Scientific, Pittsburgh, 
PA, USA. 
18. Nitrocellulose membrane 0.45 micron, BIO-RAD. 
19. Bovine Serum Albumin (BSA), Sigma A-4503. 
20. Tris, Molecular Sigma Biology. 
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Buffers and Substrate Solutions 
 
1. Preparation of phosphate buffer saline (PBS) (Vacutainer System; Becton 
Dickinson, Rutherford, NJ) (pH 7.2) 
NaCl (Fischer Scientific, Pittsburgh, PA, USA)                  80.00 g  
Na2HPO4                                                                              11.50 g  
KH2PO4                                                                                  2.00 g 
KCL (Fischer Scientific, Pittsburgh, PA, USA)                 2.00 g 
Deionized water                                                                   1000.0 ml 
The concentrated solution (10xPBS) was diluted ten times and was used as working 
solution. 
2. Preparation of 1% BSA in PBS                                   (500 ml) 
Phosphate Buffer Saline (PBS)                    500 ml 
Bovine Serum Albumin (BSA)                  5 g 
 
3. Preparation of 0.1% BSA in PBS-Tween                   (500 ml) 
Phosphate Buffer Saline (PBS)                   500 ml 
Bovine Serum Albumin (BSA)                  0.5 g 
Tween          250 l 
 
4. Preparation of 0.1 M Sodium citrate buffer (pH 4.5)      (1000ml)  
Tri-natrium citrate (Na3C6H5O4.2H2O)                                   29.4 g  
H2O (deionized)                                                                        1000.0 ml         
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5.  Preparation of Orthophenylene diamine - H2O2 substrate      (10 ml)  
OPD                                                                                            10.0 mg 
0.1 M sodium citrate (pH 4.5)                                                10.0 ml  
30% H2O2                                                                                            4.0 m 
 
 
 
 
 
Media Preparation: 
 
Preparation of RPMI complete medium                                        (200 ml)  
 
RPMI 1640 (1X)                                               200 ml 
Fetal Bovine Serum (FBS- 10%)                                  20 ml 
Pen/Strp (Penicillin-Streptomycin- 1%)                                  2ml 
Na-Pyruvate (1%)                                    2ml 
L- Glutamine (1%)                         2ml 
 
Trypticase soy Broth (1000 mL) 
 
Pancreatic digest of casein                                                           15.0 g 
Papaic digest of soyabean                           5.0 g 
Sodium chloride                                              5.0 g 
Bacto agar                                                           15.0 g  
Distilled water                                                  1000 mL 
pH =7.3 + 0.2 
 
 
APPENDIX C 
106 
 
Motility Indole Urea (MIU) 
Peptone                                                                        30.0 g 
KH2PO4                                                                  2.0 g 
Sodium chloride                                                        5.0 g 
Phenol Red                                                               0.005 g 
Urea                                                                      20.0 g 
Bacto agar                                                               4.0 g 
Distilled water                                                           1000 mL 
pH =7.3+ 0.2 
 
Citrate agar (Simmons, 1926 Modified) 
NaCl                                                                        5.0 g 
MgSO4                                                                   0.2 g 
NH4PO4                                                                1.0 g 
K2HPO4                                                                1.0 g 
Sodium citrate                                                       2.0 g 
Bacto Agar                                                              20.0 g 
 
 
Muller Hinton Agar (1000 mL) 
Beef, infusion form                                                    300 g 
Casein hydrosate                                            17.5 g 
Starch                                                               1.5 g 
Bacto Agar                                                       17.0 g 
Distilled water                                                         1000 mL  
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pH =7.3+ 0.1 
 
 
 
 
 
 
Reagent Preparation: 
 
Preparation of Ammonium Chloride Lysing Solution (10X) 
Ammonium Chloride Lysing Solution (200 ml): 
1. Weighted the following reagents: 
Ammonium Chloride                                                                 16.58gm 
Potassium bicarbonate                                                                2gm 
EDTA                                                                                         0.074gm 
2. Dissolved in D/W to get desired volume in beaker. 
3. Mixed with magnetic mixer for 15 minutes. 
4. Adjust pH to 7.2 with glacial acetic acid. 
5. Filtered through a 0.2 µm filter. 
 
PBMC calculation 
After PBMCs were separated and they were resuspended in 10 ml PBS 
If the amount of cell counted in hemocytometer is X 
Then, as the sample was 2 times diluted by adding dye, 
      0.1 µl of the original sample contain= 2x cells   
So, 10 ml of the original sample contain= (2x ×10×103) cells=2x ×105 cells 
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Preparation of Tris (1000 ml) 
Tris                                                                                              2.42 gm (20mM) 
NaCl                                                                                            29.22 gm (0.5M) 
Adjust pH 7.5 with 6M HCl and made up final volume with deionized water to 1L 
(dissolve in approximately 600 ml deionized water). 
 
Preparation of 4-CN (200ml) 
Methanol                                                                                      200 ml 
Napthol                                                                                         0.6 gm             
 
Preparation of 4-CN Substrate (10 ml) 
4-Chloro-1-Napthol (4-CN)                                                        1.7 ml 
Tris Buffer Saline (TBS)                                                             8.3 ml 
H2O2 (Hydrogen Peroxide)                                                          10 µl 
 
 
Preparation of DAB Substrate (4ml) 
Phosphate Buffer Saline                                                                 4ml 
DAB                                                                                               0.002gm 
H2O2 (Hydrogen Peroxide)                                                             6 µl 
 
Preparation of TMB 
DMSO                                                                                             10 ml 
TMB                                                                                                0.1gm    
 
Preparation of TMB Substrate (5ml)   
Na-acetate                                                                                        2.5 ml 
Deionized water                                                                               2.5 ml 
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Citric acid                                                                                         25 µl 
TMB                                                                                                 50 µl 
H2O2 (Hydrogen Peroxide)                                                              0.6 µl 
 
Composition of Tryphain Blue (100 ml) 
Sodium Chloride (NaCl)                                                                  0.81 gm 
Potassium Phosphate (K2PO4)                                                         0.06 gm 
Tryphan Blue                                                                                   0.4 gm 
Distilled Water                                                                                 100 ml 
 
Then mixed properly.Then aliquot in eppendrof tubes and seal with parafilm as 
Tryphan Blue is light sensitive.It is kept in room temperature. 
 
 
      
                                                               
 MS word  
  Endnote X 
 Ascent software 
 Microsoft excel-2007 software 
 Instat2 (Graph PAD Software 10855, USA) 
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